8-K
Current Report
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001193125-22-136748
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d337873d8k.htm…